Indeed, curcumin exhibited anticancer potency by means of suppression of IκB kinase and its oral administration was reported to suppress NF-κB in PBMCs (peripheral blood mononuclear cells) from multiple-myeloma patients [49,63]. This evidence concerns the gene NFKB1 and AL amyloidosis.